Tumour-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer.
Kradin RL, Kurnick JT, Lazarus DS, Preffer FI, Dubinett SM, Pinto CE, Gifford J, Davidson E, Grove B, Callahan RJ, et al.
Kradin RL, et al. Among authors: preffer fi.
Lancet. 1989 Mar 18;1(8638):577-80. doi: 10.1016/s0140-6736(89)91609-7.
Lancet. 1989.
PMID: 2564111
Clinical Trial.